Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Depreciation & Amortization (CF): 2023-2024

Historic Depreciation & Amortization (CF) for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $2.3 million.

  • Inhibrx Biosciences' Depreciation & Amortization (CF) fell 23.42% to $582,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 37.77%. This contributed to the annual value of $2.3 million for FY2024, which is 91.86% up from last year.
  • Inhibrx Biosciences' Depreciation & Amortization (CF) amounted to $2.3 million in FY2024, which was up 91.86% from $1.2 million recorded in FY2023.
  • In the past 5 years, Inhibrx Biosciences' Depreciation & Amortization (CF) ranged from a high of $2.3 million in FY2024 and a low of $1.2 million during FY2023.
  • Over the past 2 years, Inhibrx Biosciences' median Depreciation & Amortization (CF) value was $1.7 million (recorded in 2023), while the average stood at $1.7 million.
  • Data for Inhibrx Biosciences' Depreciation & Amortization (CF) shows a peak YoY spiked of 91.86% (in 2024) over the last 5 years.
  • Over the past 2 years, Inhibrx Biosciences' Depreciation & Amortization (CF) (Yearly) stood at $1.2 million in 2023, then spiked by 91.86% to $2.3 million in 2024.